Evidence map›Paper›PMID 28574003›Full record

ArticleIndian journal of ophthalmology2017

Antiretinal antibody- proven autoimmune retinopathy.

Sharanya Abraham, S Sudharshan, Muna Bhende, Sudha K Ganesh, Sriram Gopal

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Indian journal of ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Detection of serum anti-retinal antibodies in the Chinese patients with presumed autoimmune retinopathy.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2019
    Article
  4. Article
  5. Autoimmune retinopathy: A Review.International journal of retina and vitreous · 2018
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sharanya AbrahamSankara Nethralaya, Chennai, Tamil Nadu, India.
S SudharshanSankara Nethralaya, Chennai, Tamil Nadu, India.
Muna BhendeSankara Nethralaya, Chennai, Tamil Nadu, India.
Sudha K GaneshSankara Nethralaya, Chennai, Tamil Nadu, India.
Sriram GopalAthreya Retinal Centre, Trichy, Tamil Nadu, India.
Sankara Nethralaya · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A young female presented with bilateral subacute onset of progressive decrease in night vision and reduced peripheral field of vision. The short duration and rapid progression of symptoms along with the lack of family history of night blindness prompted a diagnosis of autoimmune retinopathy (AIR). Fundus fluorescein angiography, optical coherence tomography, visual fields, and electroretinogram were suggestive of AIR. A differential diagnosis of retinitis pigmentosa (RP) was also made. Antiretinal autoantibodies were detected in the blood sample. Treatment was with oral steroids and subsequently oral immunosuppressive agents. Visual acuity was maintained, fundus examination reverted to normal, and investigations repeated at every visit were stable with improvement in visual fields. Our case suggests that AIR, if diagnosed early and treated appropriately, may have a good outcome and should be considered in patients with an atypical presentation of RP.

Indexed as

Visual AcuityVisual FieldsAdultAutoantibodiesDiagnosis, DifferentialElectroretinographyFemaleFluorescein AngiographyFundus OculiHumansRetinaRetinal DiseasesTomography, Optical CoherenceAutoantibodies

Identifiers

PMID28574003
PMCPMC5565899
OpenAlexW2621196258

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.